oa SA Pharmaceutical Journal - New drug focus : drug info

Volume 75, Issue 9
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Oxybutynin has been well-established as an effective treatment option for symptoms of OAB. The advantages of the OROS® formulation of oxybutynin over the immediate-release formulation are its ease of use due to once daily administration and an improved tolerability profile.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error